PubMed Health⌕ Search

Biomedical subjects

M R Hurley

Publications and source records attributed to M R Hurley.

6 recordsLinked to original sources

Slow-transit constipation in childhood.

BACKGROUND/PURPOSE: Intestinal neuronal dysplasia (IND) as a cause for severe chronic constipation remains controversial. The authors have identified a deficiency of substance P (SP) immunoreactivity in the colonic nerve fibres of some children with severe constipation, and aim to correlate this with clinical features and transit studies. METHODS: Over 100 children with intractable constipation with or without soiling have been assessed by clinical questionnaire, nuclear transit study, and laparoscopic seromuscular biopsy of the colon labelled with antibodies to SP and vasoactive intestinal peptide (VIP) using immunofluorescence. RESULTS: More than 30% of children had delayed passage of meconium, and symptoms of constipation appeared by the age of 1 year in 63%. More than 80% had significant delay in colonic transit, and of these, about 80% had reduced SP immunoreactivity in the axons of the colonic circular muscle. A further 6% had heterotopic ganglion cells or hypoplastic ganglia on routine histology. CONCLUSIONS: In children with intractable constipation, features of early onset and delayed colonic transit correlated with deficiency of SP in myenteric axons. The authors propose that deficient SP immunoreactivity may be used as a histological marker for severe constipation. Defective excitatory neuromuscular transmission may be the cause of slow colonic transit.

Adolescent↗

Distributions of substance P- and VIP-immunoreactive nerve fibres in the colonic circular muscle in children.

In children with severe chronic constipation, abnormal distribution of substance P (SP) and vasoactive intestinal peptide (VIP), which represent excitatory and inhibitory nerves, respectively, has been reported. The normal distribution of these neuropeptides, however, is not well known. The aim of this study was to determine the populations of SP- and VIP-immunoreactive nerve fibres in the circular muscle of the colon in children. Surgically resected specimens were collected from a 6-year-old girl with familial polyposis coli (total colon) and nine patients with anorectal malformations aged 0-4 years (sigmoid colon). Double-labelling immunofluorescence was employed using neuron-specific enolase (NSE) with SP and NSE with VIP to count the percentage of SP- or VIP-labelled nerve fibres. These specimens showed normal submucous and myenteric plexuses stained with NSE. The population of SP- immunoreactive fibres was 15%-21% throughout the colon, and VIP was 39% in the caecum and 63%-65% in the transverse, descending, and sigmoid colon. In the four neonatal specimens (day 1 to 4), the SP population was only 1%-6% and the VIP population was also low (22%-33%). After 3 weeks of age, the populations had stabilised at 18%-26% for SP and 52%-62% for VIP. SP-immunoreactive nerve fibres were scarce in the neonatal period, and showed a rapid increase by 3 weeks and a similar though less dramatic increase in VIP-immunoreactive fibres. VIP-immunoreactive fibres were fewer in the caecum that at other colonic levels, where they accounted for 60% of NSE-labelled fibres; the SP population, however, was comparable at all levels of the colon at about 20% of NSE-labelled fibres.

Adenomatous Polyposis Coli↗

Sensitive care: choices and considerations.

Skilled nursing facilities are ideal settings for Sensitive Care Units to provide appropriate care to clients suffering from end-stage conditions. The need is particularly great in areas with a high incidence of acquired immunodeficiency syndrome (AIDS). Dedicating a unit or a number of beds to "sensitive care" can improve a facility's bottom line while providing a much-needed service.

Hospital Units↗